Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-12-21

Clinical Trial Update: Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intensive versus standard training for the insulin inhalation powder HIIP in Type 2 diabetes mellitus completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HIIP (insulin inhalation powder)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED